Pausing diabetes drugs before endoscopy may reduce stomach contents risk
NCT ID NCT06533527
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 37 times
Summary
This study looked at whether stopping certain diabetes medications (incretin-based therapies) before an upper endoscopy reduces the amount of food or liquid left in the stomach. Having too much stomach content can make the procedure harder or riskier. The study included 69 adults with type 2 diabetes or obesity who were scheduled for an upper endoscopy. Researchers compared those who paused their medication to those who continued it as usual.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic
Weston, Florida, 33331, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.